Obagi Nu-Derm Blender Rx
Obagi Nu-Derm Blender Rx is an evening topical treatment cream, specifically created to treat chloasma, melasma, freckles & other melanin issues. Obagi Nu-Derm Blender, prescription only, contains 4% hydroquinone for maximum skin lightening, skin cell turnover and anti-aging benefits.
Obagi Nu-Derm Blender Rx for Skin Bleaching And Anti-Aging
Obagi Nu-Derm Blender with 4% hydroquinone targets hyperpigmented skin and increases the absorption of the active ingredients of the Nu-Derm Rx System.
This evening topical treatment cream has been specifically created to treat chloasma, melasma, freckles & other melanin issues. Obagi Blender Rx helps lighten skin hyperpigmentation and visible signs of aging to reveal an evenly-toned, radiant, healthy complexion!
Obagi Nu-Derm RX is an anti-aging system that transforms cellular functions in all layers of the skin, helping to make skin look and act younger and healthier. Contains prescription-strength hydroquinone for gradual lightening of sun spots, age spots, and other types of discoloration.
Skin aging is a natural process, but daily sun exposure can contribute to premature aging, slowing down the turnover of skin cells between healthy new cells and old damaged cells.
Obagi Nu-Derm Blender Rx is Step #5 in the Obagi Nu-Derm Rx System. It is comprised of a special combination of prescription strength hydroquinone 4% with an activating base that offers blending and stimulation simultaneously. This formula can be used for lightening up the dark areas of the skin including signs of aging, dark spots and freckles. The Obagi Blender has been designed to work optimally with Obagi Nu-Derm Clear Rx to help improve the appearance and texture of the skin and provide uniformity to your skin tone.
Complementary Obagi Products: Obagi Nu-Derm Clear Rxl, Step #3 in the Obagi Nu-Derm System.
Contains 4% hydroquinone. Use sunscreen when exposed to sun.
CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
WARNINGS :Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
PRECAUTIONS (ALSO SEE WARNINGS):Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.
Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.